UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Clonal selection and double-hit events involving tumor suppressor genes underlie relapse in myeloma

Blood, 2016-09, Vol.128 (13), p.1735-1744

2016

Volltextzugriff (PDF)

Characterization of the molecular mechanism of the bone-anabolic activity of carfilzomib in multiple myeloma

PloS one, 2013-09, Vol.8 (9), p.e74191-e74191

2013

Volltextzugriff (PDF)

Jumping translocations of 1q12 in multiple myeloma: a novel mechanism for deletion of 17p in cytogenetically defined high-risk disease

Blood, 2014-04, Vol.123 (16), p.2504-2512

2014

Volltextzugriff (PDF)

Patterns of Central Nervous System Involvement in Relapsed and Refractory Multiple Myeloma

Clinical lymphoma, myeloma and leukemia, 2014-06, Vol.14 (3), p.211-214

2014

Volltextzugriff (PDF)

Reply to "Metronomic chemotherapy beyond misconceptions"--Haematologica 2013;98(11):e145

Haematologica (Roma), 2013-11, Vol.98 (11), p.e149-e150

2013

Volltextzugriff (PDF)

Metronomic therapy is an effective salvage treatment for heavily pre-treated relapsed/refractory multiple myeloma

Haematologica (Roma), 2013-07, Vol.98 (7), p.1147-1153

2013

Volltextzugriff (PDF)

Assessment of Total Lesion Glycolysis by 18F FDG PET/CT Significantly Improves Prognostic Value of GEP and ISS in Myeloma

Clinical cancer research, 2017-04, Vol.23 (8), p.1981-1987

2017

Volltextzugriff (PDF)

The use of molecular-based risk stratification and pharmacogenomics for outcome prediction and personalized therapeutic management of multiple myeloma

International journal of hematology, 2011-10, Vol.94 (4), p.321-333

2011

Volltextzugriff (PDF)

Pharmacogenomics of bortezomib test-dosing identifies hyperexpression of proteasome genes, especially PSMD4, as novel high-risk feature in myeloma treated with Total Therapy 3

Blood, 2011-09, Vol.118 (13), p.3512-3524

2011

Volltextzugriff (PDF)

Myeloma is characterized by stage-specific alterations in DNA methylation that occur early during myelomagenesis

The Journal of immunology (1950), 2013-03, Vol.190 (6), p.2966-2975

2013

Volltextzugriff (PDF)

Second malignancies in total therapy 2 and 3 for newly diagnosed multiple myeloma: influence of thalidomide and lenalidomide during maintenance

Blood, 2012-08, Vol.120 (8), p.1597-1600

2012

Volltextzugriff (PDF)

Evidence of an epigenetic origin for high-risk 1q21 copy number aberrations in multiple myeloma

Blood, 2015-06, Vol.125 (24), p.3756-3759

2015

Volltextzugriff (PDF)

In multiple myeloma, 14q32 translocations are nonrandom chromosomal fusions driving high expression levels of the respective partner genes

Genes chromosomes & cancer, 2014-07, Vol.53 (7), p.549-557

2014

Volltextzugriff (PDF)

A common genetic variant in 19q13·3 is associated with outcome of multiple myeloma patients treated with Total Therapy 2 and 3

British journal of haematology, 2016-09, Vol.174 (6), p.991-993

2016

Volltextzugriff (PDF)

Risk factors for MDS and acute leukemia following total therapy 2 and 3 for multiple myeloma

Blood, 2013-06, Vol.121 (23), p.4753-4757

2013

Volltextzugriff (PDF)

Enhancing cancer clonality analysis with integrative genomics

BMC bioinformatics, 2015-12, Vol.16 Suppl 13 (Suppl 13), p.S7-S7, Article S7

2015

Volltextzugriff (PDF)

Revealing the inherent heterogeneity of human malignancies by variant consensus strategies coupled with cancer clonal analysis

BMC bioinformatics, 2014-10, Vol.15 Suppl 11 (Suppl 11), p.S9-S9, Article S9

2014

Volltextzugriff (PDF)

Proteasome Inhibitors and Bone Disease

Seminars in hematology, 2012-07, Vol.49 (3), p.243-248

2012

Volltextzugriff (PDF)

Genome-wide scan identifies variant in 2q12.3 associated with risk for multiple myeloma

Blood, 2014-09, Vol.124 (12), p.2001-2003

2014

Volltextzugriff (PDF)

Prediction of cytogenetic abnormalities with gene expression profiles

Blood, 2012-05, Vol.119 (21), p.e148-e150

2012

Volltextzugriff (PDF)

Leveraging the new with the old: providing a framework for the integration of historic microarray studies with next generation sequencing

BMC bioinformatics, 2014-10, Vol.15 Suppl 11 (Suppl 11), p.S3-S3, Article S3

2014

Volltextzugriff (PDF)

Towards the integration, annotation and association of historical microarray experiments with RNA-seq

BMC bioinformatics, 2013-10, Vol.14 Suppl 14 (S14), p.S4-S4, Article S4

2013

Volltextzugriff (PDF)

Idiopathic giant abdominal lymph cyst: a case report

Journal of medical case reports, 2011-01, Vol.5 (1), p.21-21, Article 21

2011

Volltextzugriff (PDF)

DNA methylation alterations in multiple myeloma as a model for epigenetic changes in cancer

Wiley interdisciplinary reviews. Mechanisms of disease, 2010-11, Vol.2 (6), p.654-669

2010

Volltextzugriff (PDF)

Thalidomide in Total Therapy 2 Overcomes Inferior Prognosis of Myeloma with Low Expression of the Glucocorticoid Receptor Gene NR3C1

Clinical cancer research, 2012-10, Vol.18 (19), p.5499-5506

2012

Volltextzugriff (PDF)

1 – 25 von 102

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(102)
Mit Volltextzugriff
(97)

Publikationsform

Artikel
(98)
Tagungsberichte
(4)

Sprache

Englisch
(102)

Erscheinungsjahr

n.n

Thema

Humans
(44)
Science & Technology
(44)
Life Sciences & Biomedicine
(43)
Hematology
(28)
Aged
(19)
Male
(19)
Female
(18)
Multiple Myeloma - Drug Therapy
(17)
Middle Aged
(15)
Oncology
(15)
Multiple Myeloma - Genetics
(14)
Multiple Myeloma
(13)
Adult
(11)
Multiple Myeloma - Pathology
(11)
Biological And Medical Sciences
(10)
Medical Sciences
(10)
Prognosis
(10)
Aged, 80 And Over
(9)
Hematologic And Hematopoietic Diseases
(9)
Multiple Myeloma - Diagnosis
(9)

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

Blood
(46)
Haematologica
(5)
Urology
(5)
Bmc Bioinformatics
(4)
Clinical Cancer Research
(4)
Journal Of Clinical Oncology
(4)
Seminars In Hematology
(4)
Clinical Lymphoma, Myeloma And Leukemia
(3)
Leukemia
(3)
Blood Cancer Journal
(2)

5 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 90 Tagen
(1)

Menü

Weitere Dienste

Einstellungen

Clonal selection and double-hit events involving tumor suppressor genes underlie relapse in myeloma

Characterization of the molecular mechanism of the bone-anabolic activity of carfilzomib in multiple myeloma

Jumping translocations of 1q12 in multiple myeloma: a novel mechanism for deletion of 17p in cytogenetically defined high-risk disease

Patterns of Central Nervous System Involvement in Relapsed and Refractory Multiple Myeloma

Reply to "Metronomic chemotherapy beyond misconceptions"--Haematologica 2013;98(11):e145

Metronomic therapy is an effective salvage treatment for heavily pre-treated relapsed/refractory multiple myeloma

Assessment of Total Lesion Glycolysis by 18F FDG PET/CT Significantly Improves Prognostic Value of GEP and ISS in Myeloma

The use of molecular-based risk stratification and pharmacogenomics for outcome prediction and personalized therapeutic management of multiple myeloma

Pharmacogenomics of bortezomib test-dosing identifies hyperexpression of proteasome genes, especially PSMD4, as novel high-risk feature in myeloma treated with Total Therapy 3

Myeloma is characterized by stage-specific alterations in DNA methylation that occur early during myelomagenesis

Second malignancies in total therapy 2 and 3 for newly diagnosed multiple myeloma: influence of thalidomide and lenalidomide during maintenance

Evidence of an epigenetic origin for high-risk 1q21 copy number aberrations in multiple myeloma

In multiple myeloma, 14q32 translocations are nonrandom chromosomal fusions driving high expression levels of the respective partner genes

A common genetic variant in 19q13·3 is associated with outcome of multiple myeloma patients treated with Total Therapy 2 and 3

Risk factors for MDS and acute leukemia following total therapy 2 and 3 for multiple myeloma

Enhancing cancer clonality analysis with integrative genomics

Revealing the inherent heterogeneity of human malignancies by variant consensus strategies coupled with cancer clonal analysis

Proteasome Inhibitors and Bone Disease

Genome-wide scan identifies variant in 2q12.3 associated with risk for multiple myeloma

Prediction of cytogenetic abnormalities with gene expression profiles

Leveraging the new with the old: providing a framework for the integration of historic microarray studies with next generation sequencing

Towards the integration, annotation and association of historical microarray experiments with RNA-seq

Idiopathic giant abdominal lymph cyst: a case report

DNA methylation alterations in multiple myeloma as a model for epigenetic changes in cancer

Thalidomide in Total Therapy 2 Overcomes Inferior Prognosis of Myeloma with Low Expression of the Glucocorticoid Receptor Gene NR3C1

Suchergebnisse filtern